Gene therapy in wound healing

Present status and future directions

Ludwik Branski, C. T. Pereira, David Herndon, M. G. Jeschke

Research output: Contribution to journalArticle

54 Citations (Scopus)

Abstract

Gene therapy was traditionally considered a treatment modality for patients with congenital defects of key metabolic functions or late-stage malignancies. The realization that gene therapy applications were much vaster has opened up endless opportunities for therapeutic genetic manipulations, especially in the skin and external wounds. Cutaneous wound healing is a complicated, multistep process with numerous mediators that act in a network of activation and inhibition processes. Gene delivery in this environment poses a particular challenge. Numerous models of gene delivery have been developed, including naked DNA application, viral transfection, high-pressure injection, liposomal delivery, and more. Of the various methods for gene transfer, cationic cholesterol-containing liposomal constructs are emerging as a method with great potential for non-viral gene transfer in the wound. This article aims to review the research on gene therapy in wound healing and possible future directions in this exciting field.

Original languageEnglish (US)
Pages (from-to)1-10
Number of pages10
JournalGene Therapy
Volume14
Issue number1
DOIs
StatePublished - Jan 2007

Fingerprint

Genetic Therapy
Wound Healing
Genes
Skin
Viral DNA
Wounds and Injuries
Transfection
Cholesterol
Pressure
Injections
Direction compound
Therapeutics
Research
Neoplasms

Keywords

  • Gene transfer
  • Growth factors
  • Liposomes
  • Wound healing

ASJC Scopus subject areas

  • Genetics

Cite this

Gene therapy in wound healing : Present status and future directions. / Branski, Ludwik; Pereira, C. T.; Herndon, David; Jeschke, M. G.

In: Gene Therapy, Vol. 14, No. 1, 01.2007, p. 1-10.

Research output: Contribution to journalArticle

Branski, Ludwik ; Pereira, C. T. ; Herndon, David ; Jeschke, M. G. / Gene therapy in wound healing : Present status and future directions. In: Gene Therapy. 2007 ; Vol. 14, No. 1. pp. 1-10.
@article{4cebea2125a241b2b7cefe9e1125b738,
title = "Gene therapy in wound healing: Present status and future directions",
abstract = "Gene therapy was traditionally considered a treatment modality for patients with congenital defects of key metabolic functions or late-stage malignancies. The realization that gene therapy applications were much vaster has opened up endless opportunities for therapeutic genetic manipulations, especially in the skin and external wounds. Cutaneous wound healing is a complicated, multistep process with numerous mediators that act in a network of activation and inhibition processes. Gene delivery in this environment poses a particular challenge. Numerous models of gene delivery have been developed, including naked DNA application, viral transfection, high-pressure injection, liposomal delivery, and more. Of the various methods for gene transfer, cationic cholesterol-containing liposomal constructs are emerging as a method with great potential for non-viral gene transfer in the wound. This article aims to review the research on gene therapy in wound healing and possible future directions in this exciting field.",
keywords = "Gene transfer, Growth factors, Liposomes, Wound healing",
author = "Ludwik Branski and Pereira, {C. T.} and David Herndon and Jeschke, {M. G.}",
year = "2007",
month = "1",
doi = "10.1038/sj.gt.3302837",
language = "English (US)",
volume = "14",
pages = "1--10",
journal = "Gene Therapy",
issn = "0969-7128",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - Gene therapy in wound healing

T2 - Present status and future directions

AU - Branski, Ludwik

AU - Pereira, C. T.

AU - Herndon, David

AU - Jeschke, M. G.

PY - 2007/1

Y1 - 2007/1

N2 - Gene therapy was traditionally considered a treatment modality for patients with congenital defects of key metabolic functions or late-stage malignancies. The realization that gene therapy applications were much vaster has opened up endless opportunities for therapeutic genetic manipulations, especially in the skin and external wounds. Cutaneous wound healing is a complicated, multistep process with numerous mediators that act in a network of activation and inhibition processes. Gene delivery in this environment poses a particular challenge. Numerous models of gene delivery have been developed, including naked DNA application, viral transfection, high-pressure injection, liposomal delivery, and more. Of the various methods for gene transfer, cationic cholesterol-containing liposomal constructs are emerging as a method with great potential for non-viral gene transfer in the wound. This article aims to review the research on gene therapy in wound healing and possible future directions in this exciting field.

AB - Gene therapy was traditionally considered a treatment modality for patients with congenital defects of key metabolic functions or late-stage malignancies. The realization that gene therapy applications were much vaster has opened up endless opportunities for therapeutic genetic manipulations, especially in the skin and external wounds. Cutaneous wound healing is a complicated, multistep process with numerous mediators that act in a network of activation and inhibition processes. Gene delivery in this environment poses a particular challenge. Numerous models of gene delivery have been developed, including naked DNA application, viral transfection, high-pressure injection, liposomal delivery, and more. Of the various methods for gene transfer, cationic cholesterol-containing liposomal constructs are emerging as a method with great potential for non-viral gene transfer in the wound. This article aims to review the research on gene therapy in wound healing and possible future directions in this exciting field.

KW - Gene transfer

KW - Growth factors

KW - Liposomes

KW - Wound healing

UR - http://www.scopus.com/inward/record.url?scp=33845654015&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33845654015&partnerID=8YFLogxK

U2 - 10.1038/sj.gt.3302837

DO - 10.1038/sj.gt.3302837

M3 - Article

VL - 14

SP - 1

EP - 10

JO - Gene Therapy

JF - Gene Therapy

SN - 0969-7128

IS - 1

ER -